GAP43 and Alzheimer disease: Remarkably, in the investigation of neuroplasticity activity in the brain of Alzheimer’s disease, Rekart et al. found subfield-specific elevation of GAP-43 expression in the hippocampus and stratum lacunosum that was associated with the severity of the disease [321].